Claudia Un-Yong Chae, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Perimenopause | 3 | 2011 | 139 | 0.690 |
Why?
|
Postmenopause | 6 | 2019 | 2456 | 0.390 |
Why?
|
Heart Failure | 15 | 2019 | 10793 | 0.380 |
Why?
|
Vitamin E | 2 | 2012 | 870 | 0.320 |
Why?
|
Women's Health | 5 | 2022 | 2029 | 0.320 |
Why?
|
Blood Pressure | 9 | 2016 | 8554 | 0.270 |
Why?
|
Primary Prevention | 2 | 2012 | 1165 | 0.270 |
Why?
|
Antioxidants | 2 | 2012 | 1659 | 0.260 |
Why?
|
Premenopause | 3 | 2008 | 1028 | 0.260 |
Why?
|
Hematocrit | 1 | 2005 | 636 | 0.240 |
Why?
|
Dyspnea | 7 | 2012 | 1295 | 0.220 |
Why?
|
Coronary Disease | 13 | 2009 | 6068 | 0.220 |
Why?
|
Chest Pain | 6 | 2012 | 1112 | 0.220 |
Why?
|
Estrogen Replacement Therapy | 2 | 2001 | 1203 | 0.210 |
Why?
|
Cardiovascular Diseases | 10 | 2020 | 15070 | 0.210 |
Why?
|
Renal Insufficiency | 2 | 2005 | 803 | 0.200 |
Why?
|
Anti-Mullerian Hormone | 1 | 2022 | 399 | 0.180 |
Why?
|
Dietary Supplements | 2 | 2012 | 3279 | 0.170 |
Why?
|
Death, Sudden, Cardiac | 5 | 2006 | 1542 | 0.170 |
Why?
|
Lipoproteins | 2 | 2022 | 880 | 0.170 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2010 | 2044 | 0.170 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2007 | 1557 | 0.160 |
Why?
|
Peptide Fragments | 5 | 2007 | 5076 | 0.140 |
Why?
|
Anemia | 1 | 2005 | 1498 | 0.140 |
Why?
|
Hormone Replacement Therapy | 2 | 2019 | 740 | 0.130 |
Why?
|
Risk Factors | 28 | 2020 | 71974 | 0.120 |
Why?
|
Hypertension | 7 | 2017 | 8431 | 0.120 |
Why?
|
Menopause | 3 | 2022 | 1613 | 0.120 |
Why?
|
Troponin I | 3 | 2005 | 616 | 0.120 |
Why?
|
Hot Flashes | 1 | 2016 | 316 | 0.120 |
Why?
|
Lipids | 3 | 2005 | 3307 | 0.110 |
Why?
|
Triage | 3 | 2010 | 975 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 630 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 879 | 0.110 |
Why?
|
Risk Assessment | 5 | 2020 | 23294 | 0.100 |
Why?
|
Middle Aged | 41 | 2022 | 212863 | 0.100 |
Why?
|
Myocardial Infarction | 9 | 2012 | 11668 | 0.100 |
Why?
|
Physical Exertion | 2 | 2006 | 695 | 0.090 |
Why?
|
Population Surveillance | 1 | 2020 | 2629 | 0.090 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5003 | 0.090 |
Why?
|
Coronary Angiography | 4 | 2012 | 4560 | 0.090 |
Why?
|
Female | 44 | 2022 | 378853 | 0.090 |
Why?
|
Prospective Studies | 22 | 2018 | 53037 | 0.080 |
Why?
|
Flavones | 1 | 2007 | 65 | 0.070 |
Why?
|
United States | 17 | 2020 | 69573 | 0.070 |
Why?
|
Acute Disease | 9 | 2010 | 7128 | 0.070 |
Why?
|
Flavonols | 1 | 2007 | 82 | 0.070 |
Why?
|
Coronary Stenosis | 3 | 2010 | 836 | 0.070 |
Why?
|
Aged | 27 | 2019 | 162698 | 0.070 |
Why?
|
Triglycerides | 3 | 2022 | 2447 | 0.070 |
Why?
|
Tyrosine | 2 | 2001 | 1460 | 0.070 |
Why?
|
Angina, Unstable | 3 | 2006 | 926 | 0.070 |
Why?
|
Acute Coronary Syndrome | 2 | 2010 | 2331 | 0.070 |
Why?
|
Aging | 2 | 2009 | 8613 | 0.070 |
Why?
|
Myoglobin | 1 | 2005 | 160 | 0.070 |
Why?
|
Aging, Premature | 1 | 2005 | 47 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3233 | 0.070 |
Why?
|
Humans | 50 | 2022 | 739398 | 0.070 |
Why?
|
Incidence | 5 | 2017 | 20913 | 0.070 |
Why?
|
alpha-Linolenic Acid | 1 | 2005 | 144 | 0.060 |
Why?
|
Cholesterol | 2 | 2011 | 2900 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 912 | 0.060 |
Why?
|
Linear Models | 4 | 2009 | 5948 | 0.060 |
Why?
|
Creatine Kinase, MB Form | 1 | 2005 | 214 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2010 | 20055 | 0.060 |
Why?
|
Streptococcus anginosus | 1 | 2004 | 24 | 0.060 |
Why?
|
Lamin Type A | 1 | 2005 | 189 | 0.060 |
Why?
|
Angina Pectoris | 2 | 2005 | 976 | 0.060 |
Why?
|
Creatinine | 3 | 2005 | 1903 | 0.060 |
Why?
|
Diabetes Complications | 3 | 2017 | 1356 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2019 | 38942 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2019 | 11985 | 0.060 |
Why?
|
Cause of Death | 3 | 2011 | 3564 | 0.060 |
Why?
|
Cohort Studies | 10 | 2017 | 40389 | 0.050 |
Why?
|
Coronary Artery Disease | 4 | 2012 | 6416 | 0.050 |
Why?
|
Body Height | 1 | 2009 | 1577 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2005 | 438 | 0.050 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 548 | 0.050 |
Why?
|
Acetaminophen | 1 | 2006 | 541 | 0.050 |
Why?
|
Body Mass Index | 6 | 2017 | 12655 | 0.050 |
Why?
|
Inflammation | 1 | 2001 | 10534 | 0.050 |
Why?
|
Blood Glucose | 3 | 2011 | 6237 | 0.050 |
Why?
|
Exercise | 3 | 2018 | 5591 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2022 | 281 | 0.050 |
Why?
|
Insulin | 3 | 2011 | 6569 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4022 | 0.050 |
Why?
|
Risk | 7 | 2011 | 9684 | 0.050 |
Why?
|
Apolipoproteins B | 1 | 2022 | 373 | 0.050 |
Why?
|
Male | 27 | 2011 | 349022 | 0.050 |
Why?
|
Multivariate Analysis | 5 | 2007 | 12237 | 0.050 |
Why?
|
Abscess | 1 | 2004 | 605 | 0.050 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2001 | 641 | 0.050 |
Why?
|
Time Factors | 5 | 2012 | 40050 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2012 | 3087 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.050 |
Why?
|
Prothrombin | 1 | 2001 | 185 | 0.050 |
Why?
|
Adult | 23 | 2022 | 213394 | 0.050 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2001 | 128 | 0.050 |
Why?
|
Endocarditis, Bacterial | 1 | 2004 | 453 | 0.050 |
Why?
|
Streptococcal Infections | 1 | 2004 | 635 | 0.050 |
Why?
|
C-Reactive Protein | 2 | 2009 | 3752 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10208 | 0.040 |
Why?
|
Fibrinolysis | 1 | 2001 | 322 | 0.040 |
Why?
|
Sensitivity and Specificity | 7 | 2010 | 14740 | 0.040 |
Why?
|
Hemostasis | 2 | 2005 | 459 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2016 | 13880 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1413 | 0.040 |
Why?
|
Systole | 3 | 2010 | 956 | 0.040 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2019 | 162 | 0.040 |
Why?
|
Estradiol | 2 | 2022 | 2021 | 0.040 |
Why?
|
Endothelium | 1 | 2001 | 776 | 0.040 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2019 | 275 | 0.040 |
Why?
|
beta Carotene | 1 | 1999 | 526 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2864 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2001 | 1153 | 0.040 |
Why?
|
Androgens | 1 | 2005 | 1270 | 0.040 |
Why?
|
Proportional Hazards Models | 5 | 2009 | 12328 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2001 | 677 | 0.040 |
Why?
|
Predictive Value of Tests | 6 | 2010 | 15036 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2001 | 424 | 0.040 |
Why?
|
Emergency Service, Hospital | 5 | 2009 | 7626 | 0.040 |
Why?
|
Aged, 80 and over | 11 | 2007 | 57650 | 0.040 |
Why?
|
Heart Valve Diseases | 1 | 2004 | 1058 | 0.040 |
Why?
|
Heparin | 2 | 2001 | 1637 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1807 | 0.030 |
Why?
|
Alopecia | 1 | 2000 | 376 | 0.030 |
Why?
|
Smoking | 4 | 2018 | 8960 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2277 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 549 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2039 | 0.030 |
Why?
|
Vasomotor System | 1 | 2016 | 210 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2005 | 1201 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3401 | 0.030 |
Why?
|
Survival Rate | 3 | 2007 | 12761 | 0.030 |
Why?
|
Diet | 2 | 2018 | 7876 | 0.030 |
Why?
|
ROC Curve | 3 | 2009 | 3526 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2008 | 24714 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1763 | 0.030 |
Why?
|
Syndrome | 3 | 2006 | 3241 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2016 | 213 | 0.030 |
Why?
|
Aortic Valve | 1 | 2004 | 1900 | 0.030 |
Why?
|
Hypotension | 1 | 2000 | 881 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2011 | 3066 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2009 | 1585 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2012 | 12948 | 0.030 |
Why?
|
Diastole | 2 | 2010 | 791 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2334 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1997 | 976 | 0.030 |
Why?
|
Myocardial Ischemia | 2 | 2001 | 2146 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4463 | 0.030 |
Why?
|
Obesity | 3 | 2017 | 12643 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2001 | 3194 | 0.030 |
Why?
|
Stroke Volume | 2 | 2019 | 4941 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2012 | 76631 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 2149 | 0.020 |
Why?
|
Age Factors | 2 | 2006 | 18349 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1999 | 6370 | 0.020 |
Why?
|
Factor VII | 1 | 2009 | 139 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2005 | 15511 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2012 | 62693 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2009 | 281 | 0.020 |
Why?
|
Stroke | 1 | 2011 | 9898 | 0.020 |
Why?
|
Prevalence | 1 | 2005 | 15153 | 0.020 |
Why?
|
Kaempferols | 1 | 2007 | 21 | 0.020 |
Why?
|
Brassica | 1 | 2007 | 38 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2009 | 223 | 0.020 |
Why?
|
Hemodynamics | 1 | 1997 | 4197 | 0.020 |
Why?
|
Odds Ratio | 2 | 2009 | 9846 | 0.020 |
Why?
|
Electrocardiography | 2 | 2012 | 6426 | 0.020 |
Why?
|
Fibrinogen | 1 | 2009 | 895 | 0.020 |
Why?
|
Nurses | 2 | 2007 | 2455 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16764 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2006 | 188 | 0.020 |
Why?
|
Heart Murmurs | 1 | 2006 | 94 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1655 | 0.020 |
Why?
|
Anticoagulants | 1 | 2000 | 4582 | 0.020 |
Why?
|
Rest | 1 | 2010 | 904 | 0.020 |
Why?
|
California | 1 | 2009 | 1400 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 7897 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2006 | 637 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 2 | 2005 | 2265 | 0.020 |
Why?
|
Glucuronidase | 1 | 2005 | 207 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 320 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17384 | 0.010 |
Why?
|
Hospitals, University | 1 | 2005 | 567 | 0.010 |
Why?
|
Prognosis | 2 | 2017 | 28901 | 0.010 |
Why?
|
Anthropometry | 1 | 2008 | 1344 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2974 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1734 | 0.010 |
Why?
|
Vitamins | 1 | 2011 | 1602 | 0.010 |
Why?
|
Physicians | 1 | 2001 | 4539 | 0.010 |
Why?
|
Delphi Technique | 1 | 2005 | 770 | 0.010 |
Why?
|
Protein Precursors | 1 | 2005 | 1154 | 0.010 |
Why?
|
Japan | 1 | 2005 | 1348 | 0.010 |
Why?
|
Pulse | 1 | 2000 | 229 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2001 | 6478 | 0.010 |
Why?
|
Comorbidity | 2 | 2005 | 10362 | 0.010 |
Why?
|
Troponin T | 1 | 2005 | 748 | 0.010 |
Why?
|
Aspirin | 1 | 2011 | 3268 | 0.010 |
Why?
|
China | 1 | 2005 | 2225 | 0.010 |
Why?
|
Physical Examination | 1 | 2005 | 1231 | 0.010 |
Why?
|
Analgesics | 1 | 2006 | 1034 | 0.010 |
Why?
|
Observer Variation | 1 | 2005 | 2589 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2005 | 1123 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2000 | 694 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1650 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1128 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2005 | 1143 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2005 | 2184 | 0.010 |
Why?
|
Health Personnel | 1 | 2011 | 3203 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1874 | 0.010 |
Why?
|
Fever | 1 | 2004 | 1607 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5293 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 21694 | 0.010 |
Why?
|
Life Style | 1 | 2008 | 3817 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2005 | 1890 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1999 | 11699 | 0.010 |
Why?
|
Preoperative Care | 1 | 2004 | 2238 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2272 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2881 | 0.010 |
Why?
|
Heart Rate | 1 | 2006 | 4095 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9812 | 0.010 |
Why?
|
Testosterone | 1 | 2005 | 2391 | 0.010 |
Why?
|
Overweight | 1 | 2005 | 2355 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6295 | 0.010 |
Why?
|
Echocardiography | 1 | 2005 | 5098 | 0.010 |
Why?
|
Boston | 1 | 2005 | 9314 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2005 | 3945 | 0.010 |
Why?
|
Logistic Models | 1 | 2007 | 13402 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12951 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10398 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6452 | 0.010 |
Why?
|
Kidney | 1 | 2005 | 7144 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5702 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2005 | 7862 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7136 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2005 | 15500 | 0.000 |
Why?
|